Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Prophase Labs Inc (PRPH)
Prophase Labs Inc (PRPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 86,616
  • Shares Outstanding, K 18,045
  • Annual Sales, $ 122,650 K
  • Annual Income, $ 18,460 K
  • 60-Month Beta -0.26
  • Price/Sales 0.71
  • Price/Cash Flow 3.43
  • Price/Book 1.48
Trade PRPH with:

Options Overview Details

View History
  • Implied Volatility 58.99% ( +16.02%)
  • Historical Volatility 52.29%
  • IV Percentile 22%
  • IV Rank 51.30%
  • IV High 99.32% on 02/06/23
  • IV Low 16.52% on 08/11/23
  • Put/Call Vol Ratio 0.75
  • Today's Volume 35
  • Volume Avg (30-Day) 18
  • Put/Call OI Ratio 0.50
  • Today's Open Interest 490
  • Open Int (30-Day) 554

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.26
  • Number of Estimates 2
  • High Estimate -0.25
  • Low Estimate -0.27
  • Prior Year -0.08
  • Growth Rate Est. (year over year) -225.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.25 +15.29%
on 11/22/23
5.70 -14.04%
on 11/30/23
+0.32 (+6.99%)
since 11/06/23
3-Month
4.25 +15.29%
on 11/22/23
5.70 -14.04%
on 11/30/23
+0.60 (+13.95%)
since 09/06/23
52-Week
4.05 +20.99%
on 08/31/23
10.86 -54.88%
on 12/14/22
-5.19 (-51.44%)
since 12/06/22

Most Recent Stories

More News
ProPhase Labs, Inc. (PRPH) Beats Q1 Earnings and Revenue Estimates

ProPhase Labs, Inc. (PRPH) delivered earnings and revenue surprises of 130% and 18.42%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

PRPH : 4.80 (unch)
ONTX : 0.6510 (-6.49%)
Foghorn Therapeutics Inc. (FHTX) Reports Q1 Loss, Lags Revenue Estimates

Foghorn Therapeutics Inc. (FHTX) delivered earnings and revenue surprises of -7.35% and 12.88%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

FHTX : 4.45 (-1.98%)
PRPH : 4.80 (unch)
ProPhase Labs, Inc. (PRPH) Surges 8.5%: Is This an Indication of Further Gains?

ProPhase Labs, Inc. (PRPH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near...

PRPH : 4.80 (unch)
FGEN : 0.5800 (+4.56%)
Catalent (CTLT) Stock Jumps 6.8%: Will It Continue to Soar?

Catalent (CTLT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in...

CTLT : 37.95 (-2.47%)
PRPH : 4.80 (unch)
COMSovereign Names Bill White, CFE as New Independent Director and Chair of Audit Committee

/PRNewswire/ -- COMSovereign Holding Corp. (NASDAQ: COMS and COMSP) ("COMSovereign" or the "Company"), a U.S.-based developer of 4G LTE Advanced and 5G...

COMS : 0.9600 (-14.00%)
PRPH : 4.80 (unch)
ProPhase Labs, Inc. (PRPH) Soars 7.5%: Is Further Upside Left in the Stock?

ProPhase Labs, Inc. (PRPH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term....

PRPH : 4.80 (unch)
FHTX : 4.45 (-1.98%)
ProPhase Labs, Inc. (PRPH) Reports Q4 Loss, Tops Revenue Estimates

ProPhase Labs, Inc. (PRPH) delivered earnings and revenue surprises of -500% and 6.30%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

PRPH : 4.80 (unch)
BVS : 4.52 (+4.63%)
Fusion Pharmaceuticals Inc. (FUSN) Reports Q4 Loss, Tops Revenue Estimates

Fusion Pharmaceuticals Inc. (FUSN) delivered earnings and revenue surprises of 3.51% and 16.67%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the...

FUSN : 5.40 (unch)
PRPH : 4.80 (unch)
Implied Volatility Surging for ProPhase Labs (PRPH) Stock Options

Investors need to pay close attention to ProPhase Labs (PRPH) stock based on the movements in the options market lately.

PRPH : 4.80 (unch)
ProPhase Labs, Inc. (PRPH) Q3 Earnings Miss Estimates

ProPhase Labs, Inc. (PRPH) delivered earnings and revenue surprises of -60% and 28.38%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

PRPH : 4.80 (unch)
IMPL : 0.4179 (-10.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ProPhase Labs, Inc., formerly known as The Quigley Corporation, is a manufacturer, marketer and distributor of a diversified range of homeopathic and health products that are offered to the general public. The Company's mission is to develop and market natural health care pharmaceuticals and nutriceuticals...

See More

Key Turning Points

3rd Resistance Point 5.19
2nd Resistance Point 5.09
1st Resistance Point 4.94
Last Price 4.80
1st Support Level 4.70
2nd Support Level 4.60
3rd Support Level 4.45

See More

52-Week High 10.86
Fibonacci 61.8% 8.26
Fibonacci 50% 7.45
Fibonacci 38.2% 6.65
Last Price 4.80
52-Week Low 4.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar